openPR Logo
Press release

Sporadic Inclusion Body Myositis Market: Epidemiology, Pipeline, Companies, DelveInsight | Novartis Pharmaceutical, Regeneron Pharmaceuticals, ZevraDenmark, Abcuro Inc., Syneos Health, Argenx, Amgen,

09-03-2025 08:54 PM CET | Associations & Organizations

Press release from: ABNewswire

Sporadic Inclusion Body Myositis Market

Sporadic Inclusion Body Myositis Market

The Sporadic Inclusion Body Myositis market report provides current treatment practices, emerging drugs, Sporadic Inclusion Body Myositis market share of the individual therapies, current and forecasted Sporadic Inclusion Body Myositis market Size from 2019 to 2032 segmented by seven major markets.

Emerging therapies for Sporadic Inclusion Body Myositis are anticipated to drive growth in the market in the coming years.

DelveInsight has launched a new report on "Sporadic Inclusion Body Myositis - Market Insights, Epidemiology, and Market Forecast-2032" that delivers an in-depth understanding of the Sporadic Inclusion Body Myositis, historical and forecasted epidemiology as well as the Sporadic Inclusion Body Myositis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Request for a sporadic inclusion body myositis market sample page @ https://www.delveinsight.com/report-store/sporadic-inclusion-body-myositis-sibm-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr

Some of the key facts of the Sporadic Inclusion Body Myositis Market Report:

*
In May 2023, ZevraDenmark initiated a Phase 2 clinical trial to assess the safety and efficacy of Arimoclomol in patients with Inclusion Body Myositis (IBM). The following month, Abcuro Inc. launched a Phase 2/3 randomized, double-blind, placebo-controlled, multicenter study for ABC008, aimed at evaluating its safety and effectiveness in IBM patients.

*
In July 2023, Argenx began a Phase 2/3 trial of efgartigimod PH20 SC versus placebo in patients with Idiopathic Inflammatory Myopathy (IIM), including subtypes such as dermatomyositis (DM), immune-mediated necrotizing myopathy (IMNM), and certain forms of polymyositis (PM) like antisynthetase syndrome (ASyS). Treatment response will be measured using the Total Improvement Score (TIS).

*
Key companies advancing the Sporadic Inclusion Body Myositis treatment landscape include Novartis, Regeneron, ZevraDenmark, Abcuro, Syneos Health, Argenx, Amgen, Immunoforge, Janssen, Pfizer, Bristol-Myers Squibb, Eli Lilly, Roche, Octapharma, Biogen, Kezar Life Sciences, and others, all working to develop innovative therapies for IBM.

Key benefits of the Sporadic Inclusion Body Myositis market report:

*
Sporadic Inclusion Body Myositis market report covers a descriptive overview and comprehensive insight of the Sporadic Inclusion Body Myositis Epidemiology and Sporadic Inclusion Body Myositis market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)

*
The Sporadic Inclusion Body Myositis market report provides insights on the current and emerging therapies.

*
Sporadic Inclusion Body Myositis market report provides a global historical and forecasted market covering drug outreach in 7MM.

*
The Sporadic Inclusion Body Myositis market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Sporadic Inclusion Body Myositis market.

Got queries? Click here to know more about the Sporadic Inclusion Body Myositis Market Landscape [https://www.delveinsight.com/sample-request/sporadic-inclusion-body-myositis-sibm-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]

Sporadic Inclusion Body Myositis Overview

The Sporadic Inclusion Body Myositis (sIBM) treatment market has made significant strides in recent years, offering renewed hope to patients affected by this rare and debilitating disorder. sIBM is a chronic, progressive inflammatory muscle disease that primarily impacts older adults, causing muscle weakness and functional decline. Advances in understanding the disease's underlying mechanisms have enabled the development of targeted therapies and novel treatment approaches.

Sporadic Inclusion Body Myositis Market Outlook

The Sporadic Inclusion Body Myositis (sIBM) market is witnessing significant developments and challenges within the neuromuscular disorder landscape. sIBM is a rare, progressive muscle-wasting condition primarily affecting older adults. Despite diagnostic and treatment difficulties, ongoing research has improved understanding of its underlying mechanisms.

This section offers a detailed analysis of sIBM market trends, covering both approved therapies and late-stage pipeline candidates. It assesses their impact based on factors such as annual treatment costs, patient eligibility criteria, mechanisms of action, compliance rates, growing demand, expanding patient population, targeted segments, projected launch timelines, competition, brand value, and insights from key opinion leaders. The market data is illustrated with tables and graphs to provide a clear and comprehensive overview.

Discover how the sporadic inclusion body myositis market is rising in the upcoming years @ https://www.delveinsight.com/report-store/sporadic-inclusion-body-myositis-sibm-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr

Scope of the Sporadic Inclusion Body Myositis Market Report

*
Study Period: 2019-2032

*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]

*
Key Sporadic Inclusion Body Myositis Companies: Novartis Pharmaceutical, Regeneron Pharmaceuticals, ZevraDenmark, Abcuro Inc., Syneos Health, Argenx, Amgen, Immunoforge Co. Ltd, Janssen Research & Development LLC, Pfizer, Bristol-Myers Squibb, Eli Lilly and Company, Roche Pharma AG, Octapharma, Biogen, Kezar Life Sciences Inc., and others

*
Sporadic Inclusion Body Myositis Therapeutic Assessment: Sporadic Inclusion Body Myositis current marketed and Sporadic Inclusion Body Myositis emerging therapies

*
Sporadic Inclusion Body Myositis Market Dynamics: Sporadic Inclusion Body Myositis market drivers and Sporadic Inclusion Body Myositis market barriers

*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies

*
Sporadic Inclusion Body Myositis Unmet Needs, KOL's views, Analyst's views, Sporadic Inclusion Body Myositis Market Access and Reimbursement

Download our report @ https://www.delveinsight.com/sample-request/sporadic-inclusion-body-myositis-sibm-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr

Table of Contents

1. Report Introduction

2. Executive Summary

3. SWOT analysis

4. Sporadic Inclusion Body Myositis Patient Share (%) Overview at a Glance

5. Sporadic Inclusion Body Myositis Market Overview at a Glance

6. Sporadic Inclusion Body Myositis Disease Background and Overview

7. Sporadic Inclusion Body Myositis Epidemiology and Patient Population

8. Country-Specific Patient Population of Sporadic Inclusion Body Myositis

9. Sporadic Inclusion Body Myositis Current Treatment and Medical Practices

10. Unmet Needs

11. Sporadic Inclusion Body Myositis Emerging Therapies

12. Sporadic Inclusion Body Myositis Market Outlook

13. Country-Wise Sporadic Inclusion Body Myositis Market Analysis (2019-2032)

14. Market Access and Reimbursement of Therapies

15. Market drivers

16. Market barriers

17. Appendix

18. Sporadic Inclusion Body Myositis Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

Click here to read more about Sporadic Inclusion Body Myositis Market Outlook 2032 [https://www.delveinsight.com/report-store/sporadic-inclusion-body-myositis-sibm-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]

Related Reports:

Sporadic Inclusion Body Myositis Pipeline Insights, DelveInsight

"Sporadic Inclusion Body Myositis Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Sporadic Inclusion Body Myositis market. A detailed picture of the Sporadic Inclusion Body Myositis pipeline landscape is provided, which includes the disease overview and Sporadic Inclusion Body Myositis treatment guidelines.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=sporadic-inclusion-body-myositis-market-epidemiology-pipeline-companies-delveinsight-novartis-pharmaceutical-regeneron-pharmaceuticals-zevradenmark-abcuro-inc-syneos-health-argenx-amgen]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Sporadic Inclusion Body Myositis Market: Epidemiology, Pipeline, Companies, DelveInsight | Novartis Pharmaceutical, Regeneron Pharmaceuticals, ZevraDenmark, Abcuro Inc., Syneos Health, Argenx, Amgen, here

News-ID: 4168824 • Views:

More Releases from ABNewswire

Parkinson's Disease Levodopa-Induced Dyskinesia Market: Epidemiology, Therapies, Companies, DelveInsight | PharmaTher Inc., Neurolixis SAS, Gala laboratories, Bukwang Pharmaceutical, Contera Pharma, V
Parkinson's Disease Levodopa-Induced Dyskinesia Market: Epidemiology, Therapies, …
The Parkinson's Disease Levodopa-induced Dyskinesia Treatment Market Report provides current treatment practices, emerging drugs, market share of individual therapies, and current and forecasted 7MM Parkinson's disease Levodopa-induced Dyskinesia market size from 2020 to 2034. The report also covers Parkinson's Disease Levodopa-induced Dyskinesia Treatment Market practices/algorithms and unmet medical needs to curate the best opportunities and assess the market's potential. Emerging therapies like GOCOVRI, JM-010, and NLX-112 are anticipated to drive growth
SSR Law Offices Expands Personalized Legal Services to Roseville and Chesterfield, Michigan, Offering Trusted Help in Estate Planning, Elder Law, and Probate
SSR Law Offices Expands Personalized Legal Services to Roseville and Chesterfiel …
Image: https://www.abnewswire.com/upload/2025/09/145941fd072173357ff31f80d29bb133.jpg SSR Law Offices, a respected Metro Detroit law firm specializing in Estate Planning, Elder Law, and Probate, is pleased to extend its legal services to clients in Roseville and Chesterfield, Michigan. With a proven reputation for combining professionalism with a personal touch, the firm is committed to providing tailored legal solutions that bring peace of mind to individuals and families facing life's most important decisions. The need for thoughtful legal
PhilFlorist.com Revolutionizes Online Flower Delivery in the Philippines with Affordable, Premium Gift Solutions
PhilFlorist.com Revolutionizes Online Flower Delivery in the Philippines with Af …
MANILA, PHILIPPINES - As the Philippines floriculture market continues its robust growth trajectory with an anticipated CAGR of 5.8% through 2031, PhilFlorist.com emerges as a leading digital platform transforming how Filipinos send flowers to the Philippines [https://www.philflorist.com/] and celebrate life's special moments. The company's innovative approach to online flower delivery addresses the growing demand for convenient, affordable gifting solutions in the archipelago nation. The Asia Pacific cut flower market, valued at
Prostate Cancer Pipeline Analysi, 2025 by DelveInsight | Pfizer, Janssen Pharmaceutical, POINT Biopharma, Tavanta Therapeutics, Exelixis, Astellas Pharma Inc., Antev, ORCA Therapeutics, Regeneron Phar
Prostate Cancer Pipeline Analysi, 2025 by DelveInsight | Pfizer, Janssen Pharmac …
DelveInsight's, "Prostate Cancer - Pipeline Insight, 2025," report provides comprehensive insights about 140+ companies and 150+ pipeline drugs in Prostate Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Prostate Cancer pipeline companies are Silenseed LTD, Lantheus, Pantarhei Oncology,

All 5 Releases


More Releases for Inclusion

Schneider Electric Bags Gender Inclusion Award
Schneider Electric, a global leader in energy management and automation, has been recognised for its commitment to gender diversity and inclusion across its African operations. The company was named the recipient of the Gender Leader Award at the 2025 edition of the Africa CEO Forum, held in Abidjan, Cote d'Ivoire, from May 12 to 13. The award, which was announced on Tuesday, acknowledged organisations operating on the continent that have demonstrated sustained
New business book "Inclusion Driven Performance" by Mariana Fagnilli is released …
Inclusion Driven Performance: A Framework to Unlock Human Potential and Achieve Organizational Excellence by Mariana Fagnilli has been released worldwide. This 334-page business book offers a bold and visionary approach to organizational strategy by placing inclusion not as a moral concept or a compliance requirement, but as a core driver of business performance. Challenging outdated assumptions that frame inclusion as a "nice-to-have," Fagnilli repositions it as a strategic advantage - essential
Mobile Money Market: Revolutionizing Financial Inclusion
The mobile money market has emerged as a transformative force in the global financial landscape, empowering individuals and businesses with convenient and accessible financial services through their mobile phones. This post will delve into the market, exploring its size, share, opportunities, challenges, demand, and trends. Market Size and Share The mobile money market is a substantial segment of the global financial technology industry. While precise figures can vary depending on data sources
18+ Show is here and reaching for National Inclusion
[Accra, 13 November, 2024] - Viewplus, an African-focused entertainment brand under MC Multimedia, proudly announces the launch of its maiden event, 18+ (Spoken Word meets Creativity), in partnership with Beyond the Return Secretariat and the Ghana Tourism Authority. About 18+ Show 18+ Show aims to spread the power of Spoken Word performances (a form of performance poetry) across Ghana and Africa, showcasing talented artists and wordsmiths. The platform offers budding talents a
Ranakpur - Kumbhalgarh Tiger Reserve. Inclusion of Old safari routes
Mana Hotels is pleased to share the progress in the development of the Tiger Reserve in the Ranakpur region of the Kumbhalgarh National Forest reserve of Southern Rajasthan. The site of the reserve located about 6 km from the Ranakpur Jain Temple is located on the highway itself making it easily accessible to the tourists travelling between Udaipur & Jodhpur. The total area under development for this reserve is 211
Enhancing Digital Inclusion: Unveiling Our Comprehensive Accessibility Audit Ser …
We have our accessibility expertEqual access is a basic human right, and discrimination against people with disabilities is strictly prescribed under any circumstances. Inclusion has an even bigger connotation in the digital world. The rapid expansion of technology and the evolving business dynamics have virtually changed the business mindset over the years. Accessibility, often heard in the digital generation, is becoming a necessary mantra for the business world. The simple meaning of